News - See what's new!

Find all the latest information on upcoming events, product developments, and company announcements.

Podcast, Part 2: What is Geographic Atrophy? Making the Invisible, Visible

Host Chris Lievens, OD chats with retinal experts, Jessica Haynes, OD and Steven Ferrucci, OD about the importance of high-quality imaging.

Read more

Podcast, Part 1: What is Geographic Atrophy? Making the Invisible, Visible

Host Chris Lievens, OD sits down with retinal experts, Jessica Haynes, OD and Steven Ferrucci, OD to discuss geographic atrophy. They cover its prevalence and development, the role of high-quality imaging (SPECTRALIS, Heidelberg), and the importance of the doctor-patient relationship.

Read more

The importance of multimodal imaging in the diagnosis of AMD and geographic atrophy

The U.S. Food and Drug Administration (FDA) has approved a drug for the treatment of geographic atrophy (GA) for the first time, one of the advanced forms of dry age-related macular degeneration (AMD). The approval is considered a breakthrough in ophthalmology and finally gives patients hope of positively impacting the course of the disease.

Read more

Heidelberg Engineering appoints new distribution partner in Türkiye

Since January 1, 2023, OCULAMED Medikal Elektronik Ltd. Sti serves as the new official distribution partner in Türkiye for the growing product portfolio of Heidelberg Engineering and will continue to deliver the high standard of support and education our customers have come to expect.

Read more

OIS Podcast Episode on Heidelberg Engineering: Setting the Standards in Imaging

Sophia Pathai, MD, PhD, host of the Ophthalmic Innovation Source podcast, caught up with our Head of Corporate Strategy and Managing Director of MSI, Kfir Azoulay, as well as Tosh Vadhia, Managing Director of Heidelberg Engineering UK, to talk about the trends and opportunities in ophthalmology, including OCT-based biomarkers and artificial intelligence.

Read more

Heidelberg Engineering announces website launch of consortium dedicated to improving glaucoma detection

Heidelberg Engineering, an industry partner of the Glaucoma / Myopia OCT Phenotyping Consortium (GMOPC), welcomes the unveiling of the consortium’s official website.

Read more

Benefits of OCT before Cataract Surgery

Dr. Farrell "Toby" Tyson overviews his pre-surgery cataract workup routine and discusses his preference of imaging with SPECTRALIS as part of his patient screening process.

Read more

Diagnosing and Treating Glaucoma webinar with Swarup Swaminathan, MD

Learn how to optimize the use of SPECTRALIS in your glaucoma practice and how to identify masqueraders that often get mistakenly treated as glaucoma.

Read more

Approaches to Reviewing OCTA Images of CNV with Dr. Karl Csaky Online Webinar

During the webinar, Dr. Csaky presented four case presentations showcasing the value of OCTA imaging in clinical practice.

Read more

Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study

In this peer-reviewed long term, prospective study of patients with intermittent multiple sclerosis published in the Annals of Clinical and Translational Neurology, SPECTRALIS OCT was used to image inner retinal layers with the authors noting, “OCT has potential to estimate rates of neurodegeneration in the retina and brain.”

Read more